In Reply to Ward et al
Int J Radiat Oncol Biol Phys
.
2023 Jan 1;115(1):256-259.
doi: 10.1016/j.ijrobp.2022.10.009.
Authors
Jayant S Vaidya
1
,
Max Bulsara
2
,
Frederik Wenz
3
,
Elena Sperk
3
,
Samuele Massarut
4
,
Michael Alvarado
5
,
Norman R Williams
6
,
Chris Brew-Graves
6
,
Marcelle Bernstein
7
,
Dennis Holmes
8
,
Lorenzo Vinante
9
,
Steffi Pigorsch
10
,
Steiner Lundgren
11
,
Valery Uhl
12
,
David Joseph
13
,
Jeffrey S Tobias
14
Affiliations
1
Division of Surgery and Interventional Science, University College London, London, United Kingdom.
2
Department of Biostatistics, University of Notre Dame, Fremantle, Australia.
3
Department of Radiation Oncology, University Medical Centre Mannheim, Heidelberg University, Heidelberg, Germany.
4
Department of Surgery, Centro di Riferimento Oncologico di Aviano, Aviano, Italy.
5
Department of Surgery, University of California, San Francisco, California.
6
University College London, London, United Kingdom.
7
Patient advocate, London, UK.
8
University of Southern California, John Wayne Cancer Institute & Helen Rey Breast Cancer Foundation, Los Angeles, California.
9
Department of Radiation Oncology, Centro di Riferimento Oncologico di Aviano (CRO), Aviano, Italy.
10
Department of RadioOncology and Radiotherapy, Technical University of Munich, Munich, Germany.
11
Department of Oncology, St Olav's University Hospital, Trondheim, Norway.
12
Radiation Oncology, Summit Medical Center, Oakland, California.
13
Department of Radiation Oncology, Sir Charles Gairdner Hospital, Perth, Australia.
14
Department of Clinical Oncology, University College London Hospitals, London, United Kingdom.
PMID:
36526392
DOI:
10.1016/j.ijrobp.2022.10.009
No abstract available
Publication types
Letter